May 05, 2026
U.S. Compounding Pharmacy Market (By Pharmacy Type: Hospital-Based Compounding Pharmacies, Independent / Retail Compounding Pharmacies, Outsourced / Third-Party Compounding Pharmacies; By Product Type: Sterile Compounded Medications, Non-Sterile Comp...
April 16, 2026
U.S. 503B Compounding Pharmacies Market ( By Product Type: Sterile Compounded Drugs, Non-sterile Compounded Drugs; By Formulation Type: Injections & Infusions, Solutions, Suspensions, Creams & Gels, Capsules & Tablets; By Therapeutic Appl...
April 16, 2026
U.S. 503B Compounding Pharmacies Market ( By Product Type: Sterile Compounded Drugs, Non-sterile Compounded Drugs; By Formulation Type: Injections & Infusions, Solutions, Suspensions, Creams & Gels, Capsules & Tablets; By Therapeutic Appl...
January 05, 2026
According to market projections, the 503A U.S. compounding pharmacies sector is expected to grow from USD 4.74 billion in 2025 to USD 8.58 billion by 2035, reflecting a CAGR of 6.11%. 503A U.S. compounding pharmacies create customized medications tai...
April 07, 2026
U.S. Breast Biopsy Devices Market (By Product: Needle-based Biopsy, Localized Wires, Guidance Systems, Biopsy Tables; By Technology: Vacuum-Assisted Biopsy, Core Needle Biopsy, Fine Needle Aspiration, Image-Guided Biopsy; By Guidance Technique: Ultra...
January 21, 2026
Based on our estimations, the U.S. Cell and Gene Therapy CRO market was valued at USD 2.33 billion in 2025 and is projected to grow from USD 2.56 billion in 2026 to USD 6.02 billion by 2035, registering a CAGR of 9.95% during 2026–2035....
April 21, 2026
Projections indicate that, the U.S. immunoassay market will increase from USD 8.99 billion in 2024 to USD 14.22 billion by 2034, experiencing a CAGR of 4.93% over the next 10 years. The expansion of immunoassays in the U.S. goes beyond traditional di...
April 21, 2026
Market insights predict the global U.S. medical alert systems industry will increase from USD 2.59 billion in 2024 to USD 7.76 billion by 2034, achieving a CAGR of 11.6%. The U.S. medical alert systems market is investment by the government....
April 21, 2026
According to market projections, the U.S. smart wearables sector is expected to grow from USD 22.17 billion in 2024 to USD 132.22 billion by 2034, reflecting a CAGR of 19.72%. The U.S. Smart Wearables Market is growing because, as wearable devices co...
April 21, 2026
According to market projections, the U.S. healthcare CRM sector is expected to grow from USD 9.92 million in 2024 to USD 19.94 million by 2034, reflecting a CAGR of 7.23%. In 2024, the U.S. healthcare CRM market was dominated by the software segment....
April 21, 2026
The U.S. behavioral health market size is calculated at USD 96.9 billion in 2025 is to hit USD 159.35 billion by 2035,achieving a CAGR of 5.1% driven by rising mental health awareness, telehealth adoption, and integrated care models. Demand for servi...
March 26, 2026
U.S. AI in Biotechnology Market (By Primary Application/Use Case: Drug discovery & lead generation, Preclinical research & biomarker discovery, Clinical development & trial optimization, Bioprocessing & manufacturing optimization (PAT...
April 21, 2026
Market insights predict the U.S. digital mental health market was valued at USD 7.46 billion in 2025 and is projected to reach USD 8.97 billion in 2026, expanding rapidly to approximately USD 47.13 billion by 2035 at a strong CAGR of 20.25% 2026 to 2...
April 21, 2026
The U.S. primary care market is expanding due to its growing population as well as rising women's health awareness. The South U.S. led the market due to the growing disease burden....
April 21, 2026
Market insights predict the U.S. pharmaceutical industry will increase from USD 520.4 billion in 2025 to USD 965 billion by 2035, achieving a CAGR of 6.37%. The strong presence of pharmaceutical companies and favorable regulatory support bolsters mar...
February 17, 2026
According to our projections, the U.S. protein chip sector is expected to grow from USD 812.35 million in 2025 to USD 1574.27 million by 2035, reflecting a CAGR of 6.84%....
April 21, 2026
Market insights predict, the U.S. anti-aging industry is expected to grow from USD 20.21 billion in 2024 to USD 39.6 billion by 2034, driven by a CAGR of 6.95%. The U.S. anti-aging market is expanding due to growing demand for regenerative medicines ...
April 21, 2026
Based on market forecasts, the U.S. oncology sector will expand from USD 72.79 billion in 2024 to USD 211.78 billion by 2034, experiencing a CAGR of 11.75%. The West region led the market due to the vital contribution of California in the oncology ...
January 07, 2026
According to forecasts, the U.S. liquid biopsy market was valued at USD 2.44 billion in 2025 and is projected to grow from USD 2.78 billion in 2026 to USD 8.90 billion by 2035, registering a CAGR of 13.82% (2026–2035). The U.S. liquid biopsy ma...
April 21, 2026
Based on market forecasts, the U.S. Controlled Substance market, projected at USD 52.3 billion in 2024, is expected to reach USD 84.95 billion by 2034, growing at a CAGR of 5.24% over the forecast period. The U.S. Controlled Substance Market is growi...
February 06, 2026
The U.S. pharmaceutical CDMO market size is calculated at USD 39.13 bn in 2025 is to hit USD 72.98 bn by 2035. The U.S. Pharmaceutical CDMO market is evolving with key developments in 2024. Recipharm partnered with Exela Pharma for sterile manufactur...
April 21, 2026
Market insights predict, the U.S. home medical equipment industry is expected to grow from USD 7.79 billion in 2024 to USD 14.25 billion by 2034, driven by a CAGR of 6.4%. The U.S. home medical equipment market is growing due to the rising geriatric ...
April 21, 2026
Market insights predict, the U.S. pharmaceutical water industry is expected to grow from USD 7.11 billion in 2024 to USD 17.04 billion by 2034, driven by a CAGR of 8.94%. Rising demand for injectable drugs, vaccines, biologics, and biosimilars, which...
April 21, 2026
Based on market forecasts, the U.S. osteoarthritis therapeutics market, projected at USD 3.27 billion in 2024, is expected to reach USD 6.46 billion by 2034, growing at a CAGR of 7.14% over the forecast period. The severe disease burden, the limited ...
April 21, 2026
Market insights predict, the U.S. laboratory revenue cycle management industry is expected to grow from USD 14.27 billion in 2024 to USD 41.27 billion by 2034, driven by a CAGR of 11.59%.The U.S. laboratory revenue cycle management market is expandin...
January 02, 2026
Market insights predict, the U.S. Tuberculosis (TB) Diagnostics Market was valued at USD 650.8 million in 2025 and is projected to reach USD 687.51 million in 2026, further expanding to USD 1,126.5 million by 2035 at a CAGR of 5.64% (2026–...
April 21, 2026
The U.S. dental market was valued at USD 13.04 billion in 2025 and is expected to reach USD 14.61 billion by 2026, further expanding to approximately USD 40.69 billion by 2035, growing at a CAGR of 12.05% from 2026 to 2035. This report provides in-de...
April 21, 2026
Market insights predict the U.S. drug utilization management industry will increase from USD 42.80 billion in 2025 to USD 88.45 billion by 2035, achieving a CAGR of 7.53%.The growing demand for personalized care and drug safety, and favorable governm...
January 22, 2026
According to our insight, the U.S. antibody specificity testing market was valued at USD 343.71 million in 2025 and is projected to grow from USD 369.18 million in 2026 to nearly USD 702.49 billion by 2035, expanding at a CAGR of 7.41% during the for...
April 21, 2026
According to market projections, the U.S. dental insurance sector is expected to grow from USD 90.02 billion in 2024 to USD 209.46 billion by 2034, reflecting a CAGR of 8.84%. In 2024, DPPOs dominated the dental insurance market, while DHMOs are set ...
February 25, 2026
The United States AI in Oncology market was valued at USD 720.04 million in 2025 and is projected to grow from USD 921.29 million in 2026 to USD 8,467.58 million by 2035, expanding at a strong CAGR of 27.95% during 2026–2035...
January 16, 2026
Our projections indicate that, U.S. longevity & general wellness supplements industry is projected to rise from USD 6.38 billion in 2025 to USD 11.53 billion by 2035, reflecting a CAGR of 6.1% over the next decade.The growing awareness of longevi...
April 21, 2026
According to market projections, the U.S. point-of-care infectious disease testing market, valued at USD 2.1 billion in 2024, is anticipated to reach USD 5.01 billion by 2034, growing at a CAGR of 9.34% over the next decade. The expanding growth of p...
April 21, 2026
Based on market forecasts, the U.S. oncology molecular diagnostics sector will expand from USD 810 million in 2024 to USD 2570.17 million by 2034, experiencing a CAGR of 12.24%. In 2024, breast cancer dominated the market, while liver cancer is expec...
April 21, 2026
Projections indicate the U.S. child care market will increase from USD 65.13 billion in 2025 to USD 99.23 billion by 2035, experiencing a CAGR of 4.3% over the next 10 years. U.S. child care includes daycare centers, in-home providers, and preschool ...
January 16, 2026
Our projections indicate, the U.S. Cell and Gene Therapy CDMO market is experiencing exponential growth driven by expanding clinical pipelines and increasing outsourcing of complex biologics manufacturing. With revenues projected to rise from USD 4.0...
April 21, 2026
According to market projections, the U.S. biotechnology sector is expected to grow from USD 621.8 billion in 2024 to USD 2004.86 billion by 2034, reflecting a CAGR of 12.42%. The rising demand for biotechnology in healthcare is driving the market&rsq...
February 06, 2026
According to market projections, the U.S. bioreactor bags sector is expected to grow from USD 1.36 billion in 2025 to USD 7.33 billion by 2035, reflecting a CAGR of 18.34%. The growing demand for biologics and advancements in manufacturing technology...
April 21, 2026
The U.S. home infusion therapy industry is projected to rise from USD 19.56 billion in 2025 to USD 36.88 billion by 2035, reflecting a CAGR of 7.3% over the next decade. Home infusion therapy in the U.S. lets patients receive medications like antibio...
April 21, 2026
According to market projections, the U.S. house calls market, valued at USD 673.69 million in 2024, is anticipated to reach USD 1160.27 million by 2034, growing at a CAGR of 5.65% over the next decade. The U.S. house calls market is growing because i...
February 04, 2026
The growing geriatric population and the increasing number of surgeries bolster market growth. The South & Midwest region led the market owing to a robust healthcare infrastructure and the presence of key players....
April 21, 2026
According to market projections, the U.S. pain management drugs sector is expected to grow from USD 31.84 billion in 2024 to USD 44.92 billion by 2034, reflecting a CAGR of 3.64%. The U.S. pain management drugs market is growing due to rising cases o...
April 21, 2026
Based on market forecasts, the U.S. exosomes sector will expand from USD 101.07 million in 2024 to USD 1,917.72 million by 2034, experiencing a CAGR of 34.22%. The U.S. exosomes market is growing fast, driven by rising interest in regenerative medici...
April 27, 2026
U.S. Bispecific Antibody Market (By Therapeutic Area/Indication: Oncology, Immuno-inflammation/Autoimmunity, Infectious Diseases, Ophthalmology/Rare Diseases/Others; By Format/Architecture: Dual-variable/IgG-based bispecifics, T-cell Engagers, Bispec...
April 21, 2026
Market insights predict the global U.S. general surgery devices industry will increase from USD 5.69 billion in 2024 to USD 12.89 billion by 2034, achieving a CAGR of 8.53%. The U.S. general surgery devices market is expanding due to growing chronic ...
April 21, 2026
Market insights predict, the U.S. viral vector and plasmid DNA manufacturing industry is expected to grow from USD 2.85 billion in 2024 to USD 12.31 billion by 2034, driven by a CAGR of 15.72%. The boom in cell and gene therapies, advancements in per...
April 21, 2026
According to market projections, the U.S. patient monitoring devices sector is expected to grow from USD 21.4 billion in 2024 to USD 44.68 billion by 2034, reflecting a CAGR of 7.64%. In 2024, multi-parameter monitoring devices led the market, while ...
April 29, 2026
U.S. Cell and Gene Therapy Market (By Therapy Type: Cell Therapy, Gene Therapy; By Indication/Therapeutic Area: Oncology, Genetic Disorders, Neurology Disorders, Cardiovascular Diseases, Ophthalmology, Musculoskeletal/Orthopedic Disorder, Infectious ...
April 13, 2026
U.S. Wireless Cardiac Monitoring Systems Market (By Product Type: Holter Monitors, Event Monitors, Mobile Cardiac Telemetry (MCT), Implantable Cardiac Monitors (ICM), Smart Wearable Monitors: By Technology: Bluetooth-enabled Monitoring, Cellular-base...
April 21, 2026
According to market projections, the U.S. healthcare staffing sector is expected to grow from USD 19.5 billion in 2024 to USD 34.09 billion by 2034, reflecting a CAGR of 5.74%. The U.S. healthcare staffing market is growing as increasing requirements...
March 17, 2026
Our projections indicate that, the U.S. emergency department market was valued at USD 216.17 billion in 2025 and is projected to grow from USD 229.25 billion in 2026 to USD 388.96 billion by 2035, registering a CAGR of 6.05% during 2026–2035....
May 07, 2026
U.S. Cardiac Ablation Market (By Product Type: Radiofrequency (RF) Ablation Devices, Cryoablation Devices, Laser Ablation Systems, Microwave Ablation Systems, Pulsed-Field Ablation (PFA) Systems; By Application/Arrhythmia Type: Atrial Fibrillation, A...
April 21, 2026
According to market projections, the global U.S. concierge medicine market, valued at USD 7.25 billion in 2024, is anticipated to reach USD 19.36 billion by 2034, growing at a CAGR of 10.36% over the next decade. In 2024, the group segment dominated ...
April 29, 2026
U.S. Dental Services Market (By Type: Preventive Dentistry, Restorative Dentistry, Cosmetic Dentistry, Orthodontics, Periodontics, Oral & Maxillofacial Surgery, Pediatric Dentistry, Sedation & Laser Dentistry, Others; By End-Use: Dental Clini...
April 21, 2026
According to market projections, the U.S. oncology drugs sector is expected to grow from USD 95.69 billion in 2024 to USD 246.85 billion by 2034, reflecting a CAGR of 9.94%. The extensive research, scientific innovations, and the market penetration...
April 21, 2026
According to market projections, the U.S. dermatology sector is expected to grow from USD 514.58 million in 2024 to USD 1041.01 million by 2034, reflecting a CAGR of 7.3%. In 2024, cosmetic dermatology led the U.S. dermatology market by product type,...
April 21, 2026
Projections indicate that, the global U.S. genotyping market will increase from USD 7.33 billion in 2024 to USD 26.53 billion by 2034, experiencing a CAGR of 13.72% over the next 10 years. The increasing importance of genotyping in biotechnology and ...
April 30, 2026
U.S. Next Generation Sequencing Market (By Product Type: Sequencing Instruments, Consumables & Reagents, Software & Informatics Tools, Services; By Application: Clinical Diagnostics, Drug Discovery & Development, Research & Academia, ...
April 21, 2026
According to market projections, the U.S. healthcare revenue cycle management sector is expected to grow from USD 65.38 billion in 2025 to USD 195.92 billion by 2035, reflecting a CAGR of 11.6%. The U.S. healthcare revenue cycle management market is ...
April 21, 2026
Market insights predict the global U.S. healthcare ERP industry will increase from USD 2.17 billion in 2024 to USD 3.83 billion by 2034, achieving a CAGR of 5.84%. In 2024, finance & billing led the U.S. healthcare ERP market, while inventory &am...
May 04, 2026
U.S. Drug Screening Market (By Product & Service: Drug Screening Services, Laboratory-based services, On-site testing services, Drug Screening Products, Analytical Instruments, Rapid Test Kits & Devices, Urine dip cards, saliva strips Consuma...
March 20, 2026
Market insights predict, the U.S. telehealth industry is expected to grow from USD 52.77 billion in 2025 to USD 447.69 billion by 2035, driven by a CAGR of 23.84%. The market is growing due to increased demand for remote healthcare services and virtu...
February 16, 2026
Our projections indicate that, the global U.S. host cell proteins (HCPs) analysis market will increase from USD 77.86 million in 2025 to USD 170.76 million by 2035, experiencing a CAGR of 8.17% over the next 10 years....
April 21, 2026
According to market projections, the U.S. clinical trials sector is expected to grow from USD 43.45 billion in 2025 to USD 80.42 billion by 2035, reflecting a CAGR of 6.35%. The U.S. clinical trials market is growing due to rising government investme...
April 21, 2026
Projections indicate that, U.S. cell therapy industry is projected to rise from USD 6.62 billion in 2024 to USD 46.26 billion by 2034, reflecting a CAGR of 21.46% over the next decade. The increasing prevalence of chronic conditions is driving the gr...
March 25, 2026
U.S. Complementary and Alternative Medicine Market (By Intervention: Traditional Alternative Medicine & Botanicals, Mind Healing, Body Healing, External Energy Healing, Sensory Healing; By Distribution Method: Direct Sales, E-sales, Distance Corr...
March 25, 2026
U.S. Durable Medical Equipment Market (By Product: Personal Mobility Devices, Bathroom Safety Devices and Medical Furniture, Monitoring and Therapeutic Devices, Blood Glucose Monitors, Continuous Passive Motion (CPM), Infusion Pumps, Nebulizers, Oxyg...
April 15, 2026
U.S. Intravenous Solutions Market (By Product Type: Crystalloids, Colloids; By Nutritional Content: Parenteral Nutrition Solutions, Non-nutritional IV Solutions; By Volume: Small Volume Parenterals (SVP), Large Volume Parenterals (LVP);&nbs...
May 08, 2026
U.S. Clinical Trial Imaging Market (By Modality: Magnetic Resonance Imaging, Computed Tomography, Positron Emission Tomography, Ultrasound, X-ray & Others; By Therapeutic Area: Oncology, Neurology, Cardiology, Musculoskeletal Disorders, Endocrino...
April 06, 2026
U.S. Contraceptive Market (By Product Type: Hormonal Contraceptives, Oral Contraceptive Pills, Barrier Methods, Long-Acting Reversible Contraceptives (LARC), Permanent Methods, Emergency Contraceptives; By Gender: Female, Male; By Age Group: 15&ndash...
April 23, 2026
U.S. Cell and Gene Therapy Clinical Trials Market (By Phase: Phase I, Phase II, Phase III, Phase IV; By Indication: Oncology, Cardiology, CNS, Musculoskeletal, Infectious diseases, Dermatology, Endocrine, metabolic, genetic, Immunology & inflamma...
January 19, 2026
Based on market forecasts, the U.S. digital health market, projected at USD 88.38 billion in 2025, is expected to reach USD 266.5 billion by 2035, growing at a CAGR of 11.67% over the forecast period. The market is growing due to the increasing adopt...
April 21, 2026
U.S. Human Fibrinogen Concentrates Market (By Product Type: Lyophilized Fibrinogen Concentrates, Liquid Fibrinogen Concentrates, Others; By Deployment Type: On-Premise, Cloud-Based/Centralized Supply Systems, Hybrid; By Application: Surgical Bleeding...
April 21, 2026
Market insights predict, the North America clinical trials industry is expected to grow from USD 55.48 billion in 2025 to USD 99.10 billion by 2035, driven by a CAGR of 4.50%. A surge in R&D investment and research in academic institutions is fue...
May 06, 2026
U.S. Supplemental Health Market (By Product Type: Critical Illness Insurance, Accident Insurance, Hospital Indemnity Insurance, Disability Insurance, Dental Insurance, Vision Insurance, Wellness & Ancillary Covers; By Coverage Type: Individual Su...
May 06, 2026
U.S. AI in Healthcare Market (By Application: Diagnostics, Clinical Decision Support Systems, Drug Discovery & Development, Patient Monitoring & Care Management, Administrative Workflow Automation, Population Health Management; By Technology:...
March 12, 2026
According to our forecasts, the U.S. automated cell counting market was valued at USD 1.42 billion in 2025 and is projected to reach USD 1.62 billion in 2026, expanding significantly to USD 5.38 billion by 2035 at a CAGR of 14.24% from 2026 to 2035....
April 21, 2026
Market insights predict, the U.S. diagnostic imaging services industry is expected to grow from USD 140.25 billion in 2024 to USD 276.31billion by 2034, driven by a CAGR of 7.04%. The U.S. diagnostic imaging services market is growing because these s...
February 25, 2026
U.S. Physical-Therapy Clinics Back Office Software Market ( By Software Functionality: Practice Management, Billing & Revenue Cycle Management, Electronic Health Records, Analytics & Reporting, Telehealth & Remote Patient Management Integ...
April 01, 2026
U.S. Ureteral Access Sheath Market (By Product Type: Standard Ureteral Access Sheaths, Single-use Standard Sheaths, Reusable Standard Sheaths, Hydrophilic Coated Ureteral Access Sheaths, Fully Hydrophilic Coated, Partially Hydrophilic Coated, Dual-Lu...
March 25, 2026
U.S. CAR T-Cell Therapies Market (By Drug Type: Axicabtagene Ciloleucel, Tisagenlecleucel, Brexucabtagene Autoleucel, Others; By Indication: Lymphoma, Acute Lymphocytic Leukemia, Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma (MM), Others; By E...
March 10, 2026
According to our market insight calculation, the United States exoskeleton market was valued at USD 251.5 million in 2025 and is expected to grow from USD 284.55 million in 2026 to USD 864.37 million by 2035, expanding at a CAGR of 13.14% during 2026...
March 11, 2026
According to forecasts, the United States wound care centers market will grow from USD 16.1 billion in 2025 to USD 26.6 billion by 2035, with an expected CAGR of 5.15%. The U.S. wound care centers market is growing due to more chronic wounds, an agin...
April 21, 2026
According to market estimations the global generic sterile injectable market was estimated at US$ 51.23 billion in 2025 and is projected to grow to US$ 82.14 billion by 2030. In 2023, North America led the market with a 40% share. Monoclonal antibodi...
April 09, 2026
U.S. Sex Reassignment Hormone Therapy Market (By Hormone Type: Estrogen, Testosterone, Anti-androgens; By Gender Category: Male-to-Female (MTF), Female-to-Male (FTM); By Route of Administration: Oral, Injectable; By Distribution Channel: Hospitals, C...
March 23, 2026
Our projections indicate, the U.S. respiratory durable medical equipment (DME) market was valued at USD 4.05 billion in 2025 and is projected to reach USD 6.58 billion by 2035, growing at a CAGR of 4.97% from 2026 to 2035....
April 24, 2026
U.S. AI in Physical Therapy Market (By Component: Software, Services; By Deployment Mode: Cloud-Based, Server-based; By Application: Musculoskeletal (MSK) Rehabilitation, Post-Acute & Post-Surgical Rehabilitation, Neurological Rehabilitation, Spo...
February 25, 2026
According to our market insight calculation the United States AI in medical scribing market was valued at USD 496.85 million in 2025 and is projected to grow from USD 621.66 million in 2026 to USD 4,671.9 million by 2035, expanding at a CAGR of 25.12...
April 21, 2026
Market insights predict, the U.S. biopharmaceutical third-party logistics industry is expected to grow from USD 61.08 billion in 2025 to USD 127.06 billion by 2035, driven by a CAGR of 7.6%. Rising complexities and volume of biopharmaceutical product...
March 09, 2026
According to our projections, the global U.S. AR and VR in healthcare market, valued at USD 0.94 billion in 2025, is anticipated to reach USD 8.81 billion by 2035, growing at a CAGR of 25.08% over the next decade. The U.S. AR and VR in healthcare mar...
April 21, 2026
The U.S. residual DNA testing market is growing because increasing application of this testing in forensics and criminal investigations, immigration, infidelity, and paternity....
April 21, 2026
According to market projections, the global U.S. healthcare IT market, valued at USD 160.52 billion in 2024, is anticipated to reach USD 566.48 billion by 2034, growing at a CAGR of 13.44% over the next decade. The implementation of regulator...
February 24, 2026
According to our projections, the U.S. life science sector is expected to grow from USD 31.58 billion in 2025 to USD 98.52 billion by 2035, reflecting a CAGR of 12.05%. The U.S. life science market is growing strong due to the rising demand for biolo...
April 21, 2026
According to market projections, the U.S. dental services organization sector is expected to grow from USD 37.9 billion in 2024 to USD 196.5 billion by 2034, reflecting a CAGR of 17.9%. Dental Service Organizations (DSOs) support dental clinics by ma...
April 21, 2026
The U.S. oncology pharmaceutical market is expanding due to increasing cancer awareness as well as growing cancer drug development. ...
March 16, 2026
Based on our market forecasts, the U.S. AI-Driven diabetic retinopathy screening market was valued at USD 191.05 million in 2025 and is expected to grow from USD 231.59 million in 2026 to around USD 1308.85 million by 2035, expanding at a CAGR of 21....
April 21, 2026
Projections indicate that, the global U.S. patient registry software market will increase from USD 776.28 million in 2025 to USD 2646.8 million by 2035, experiencing a CAGR of 13.05% over the next 10 years. The increasing number of hospital admissi...
February 23, 2026
Based on our estimations, the U.S. small molecule innovator API CDMO market was valued at USD 9.37 billion in 2025 and reached USD 9.94 billion in 2026, and is projected to grow to USD 16.85 billion by 2035, expanding at a CAGR of 6.04% from 2026 to ...
April 21, 2026
According to market projections, the global direct oral anticoagulants (DOACs) market is projected to reach US$ 102.36 billion by 2034, growing at a CAGR of 8%. Growth is driven by rising cardiovascular cases, preference for oral Factor Xa inhibito...
April 21, 2026
The compounding pharmacy vials market is evolving fast, with innovations from glass to smart vials. These vital tools support safe, efficient drug prep, as tech like telepharmacy drives global demand for advanced prescription packaging....
January 27, 2026
Based on market forecasts, the global GCC compounding pharmacy market, projected at USD 17.91 million in 2025, is expected to reach USD 43.46 million by 2035, growing at a CAGR of 9.27% over the forecast period.The growing demand for personalized med...
April 21, 2026
According to market projections, the compounding pharmacy sector is expected to grow from USD 13.86 billion in 2024 to USD 22.91 billion by 2034, reflecting a CAGR of 5.15%, tailoring medications for unique patient needs, such as dye allergies or non...
April 21, 2026
Based on market forecasts, the automated pharmacy compounding systems sector will expand from USD 2.95 billion in 2025 to USD 5.27 billion by 2035, experiencing a CAGR of 5.98%. The global market is boosting the emergence of automated workflows to re...
April 21, 2026
Market insights predict the global non-sterile compounding pharmacy industry will increase from USD 5.97 billion in 2024 to USD 12.11 billion by 2034, achieving a CAGR of 7.34%. The rise in OTC drug demand is driving the non-sterile compounding pharm...
February 09, 2026
According to our projections, the bulk-drug compounding market was valued at USD 12.52 billion in 2025 and reached USD 13.18 billion in 2026, and it is projected to grow to USD 20.87 billion by 2035 at a CAGR of 5.24% during 2026–2035....
January 23, 2026
According to our insight calculates, the animal drug compounding market was valued at USD 1.82 billion in 2026 and is projected to reach USD 3.73 billion by 2035, expanding at a CAGR of 8.32% from 2026 to 2035....
April 21, 2026
Market insights predict, the compounding chemotherapy industry is expected to grow from USD 5.34 billion in 2024 to USD 9.97 billion by 2034, driven by a CAGR of 6.44%.The compounding chemotherapy market is growing due to rising cases of cancer and g...
February 10, 2026
According to market projections, the pharmacy automation sector is expected to grow from USD 6.99 billion in 2025 to USD 18.34 billion by 2035, reflecting a CAGR of 10.12%. In 2024, North America led the pharmacy automation market with a 42% share, w...
February 27, 2026
Market insights predict the global pharmacy automation devices industry will increase from USD 8.37 billion in 2025 to USD 21.9 billion by 2035, achieving a CAGR of 10.1%. A shortage of well-trained professionals is boosting the wider adoption of pha...
April 07, 2026
E-Pharmacy Market ( By Drug Type: Prescription Drug, OTC Drug; By Region: North America, Asia Pacific, Europe, Latin America, Middle East and Africa) Global Analysis, Size, Trends, Leading Companies, Regional Outlook and Forecast 2026 to 2035....
+1 9197 992 333
+91 93077 85324
sales@towardshealthcare.com